Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Mar 15;134(6):613–614.

Tardive dyskinesia associated with metoclopramide.

L Beuclair, R Fontaine
PMCID: PMC1490926  PMID: 3948075

Full text

PDF
613

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lavy S., Melamed E., Penchas S. Tardive dyskinesia associated with metoclopramide. Br Med J. 1978 Jan 14;1(6105):77–78. doi: 10.1136/bmj.1.6105.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Riblet L. A., Taylor D. P., Eison M. S., Stanton H. C. Pharmacology and neurochemistry of buspirone. J Clin Psychiatry. 1982 Dec;43(12 Pt 2):11–18. [PubMed] [Google Scholar]
  3. Richelson E. The newer antidepressants: structures, pharmacokinetics, pharmacodynamics, and proposed mechanisms of action. Psychopharmacol Bull. 1984 Spring;20(2):213–223. [PubMed] [Google Scholar]
  4. Tarsy D., Baldessarini R. J. The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry. 1977 Jun;12(3):431–450. [PubMed] [Google Scholar]
  5. Wiholm B. E., Mortimer O., Boethius G., Häggström J. E. Tardive dyskinesia associated with metoclopramide. Br Med J (Clin Res Ed) 1984 Feb 18;288(6416):545–547. doi: 10.1136/bmj.288.6416.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Yassa R., Ghadirian A. M., Schwartz G. Prevalence of tardive dyskinesia in affective disorder patients. J Clin Psychiatry. 1983 Nov;44(11):410–412. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES